Tsuneya Ohno
Overview
Explore the profile of Tsuneya Ohno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
324
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akiyama M, Iwase S, Horiguchi-Yamada J, Saito S, Furukawa Y, Yamada O, et al.
Cancer Lett
. 2016 Jul;
380(2):611.
PMID: 27469971
No abstract available.
2.
Komita H, Homma S, Saotome H, Zeniya M, Ohno T, Toda G
J Hepatol
. 2006 Aug;
45(5):662-72.
PMID: 16935390
Background/aims: Interleukin-12 (IL-12), a cytokine with antitumor activity, was examined for the suppressive effect on hepatocellular carcinoma (HCC) in mouse model, and its mechanism of antitumor activity was analyzed. Methods:...
3.
Tamaki S, Homma S, Enomoto Y, Komita H, Zeniya M, Ohno T, et al.
Clin Immunol
. 2005 Oct;
117(3):280-93.
PMID: 16246626
Vaccination of mice with dendritic cells loaded with Hepa1-6, well-differentiated hepatocellular carcinoma cell line (DC/Hepa1-6), induced cytotoxic T lymphocytes against Hepa1-6. Liver-specific inflammation was generated by vaccination of mice with...
4.
Homma S, Komita H, Sagawa Y, Ohno T, Toda G
Immunology
. 2005 Jul;
115(4):451-61.
PMID: 16011514
When BALA/c mice with BNL hepatocellular carcinoma (HCC) were treated with dendritic cells fused with BNL cells (DC/BNL) and recombinant murine interleukin (IL)-12, tumour development was significantly suppressed, whereas treatment...
5.
Murphy K, Wardak A, Beckett M, Lopez C, Mehta N, Kimchi E, et al.
Cancer Chemother Pharmacol
. 2005 May;
56(3):317-21.
PMID: 15887016
We examined the interaction between forphenicinol (FPL) and cyclophosphamide (CPA) or ionizing radiation (IR) on the growth of murine squamous cell carcinoma tumors SCCVII. Primary tumors were established in C3H...
6.
Nakamura M, Ogawa T, Yokono A, Nakamori S, Ohno T, Umezawa K
Biomed Pharmacother
. 2005 Mar;
59(1-2):47-50.
PMID: 15740935
The combined effect against human immunodeficiency virus (HIV) of oxanosine and 2'3'-dideoxyinosine (ddI) has been evaluated by the production of viral particles, the expression of viral antigens on cell surfaces,...
7.
Dezube B, Doweiko J, Proper J, Conway B, Hwang L, Terada M, et al.
J Clin Virol
. 2004 Nov;
31 Suppl 1:S45-7.
PMID: 15567093
Background: hNM01 is a humanized monoclonal antibody that binds to the V(3) region of the HIV-1 envelope protein gp120. This binding leads to the activation of complement and the disruption...
8.
Kikuchi T, Akasaki Y, Abe T, Fukuda T, Saotome H, Ryan J, et al.
J Immunother
. 2004 Nov;
27(6):452-9.
PMID: 15534489
Despite aggressive treatment, the median survival of patients with high-grade malignant astrocytoma is about 1 year. The authors investigated the safety and clinical response to immunotherapy using fusions of dendritic...
9.
Takagi Y, Kikuchi T, Niimura M, Ohno T
Cancer Lett
. 2004 Aug;
213(1):49-55.
PMID: 15312683
Vaccination of fusion cells (FCs) made from dendritic and tumor cells elicits anti-tumor effects. We investigated whether major histocompatibility complex (MHC) class I and II play an important role in...
10.
Irie M, Homma S, Komita H, Zeniya M, Kufe D, Ohno T, et al.
Int J Cancer
. 2004 Jun;
111(2):238-45.
PMID: 15197777
We attempted to prevent spontaneous development of liver tumors by s.c. inoculation with DCs loaded with syngeneic HCC cells in C3H/HeNCrj mice. A new cell line, MIH-2, was established from...